Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Gene Modified T Cells|BIOLOGICAL: Gene Modified T Cells and Interleukin 2
Sponsor: Roger Williams Medical Center